Omalizumab (anti-IgE) might become a therapeutic option for food allergy, not only to prevent allergic reactions after a contact with egg, but also as a complementary treatment to oral tolerance induction for egg allergy, with the purpose of reducing adverse reactions (14). This evidence concerns the gene IGHE and egg allergy.